Get started
Author

Yuyan Ling

ORCID: 0009-0002-4965-3160
Observed ORCID: 0009-0002-4965-3160
OpenAlex ID: A5040605474
MicroRNAs as Regulators of Neuroinflammation in Major Depressive Disorder
2025 · Qirui Li, Yuyan Ling, et al. · Depression and Anxiety · 6
PDF
Discovery and validation of CREB1 as a transcription target of icaritin: Implications for the treatment of depressive-like behavior
2025 · Ling Gu, Lei Li, et al. · Brain Research Bulletin · 5
Kumatakenin alleviates depressive-like behaviors by suppressing excessive autophagy in hippocampus via ATG5
2025 · Lei Li, Ling Gu, et al. · European Journal of Pharmacology · 4
Treatment of COVID-19 by monoclonal antibodies and the traditional Chinese medicine
2022 · Yuyan Ling, Yuxuan Dong, et al. · Medicine in Novel Technology and Devices · 3
PDF
Agrimoniin combines with erlotinib to inhibit the proliferation of pancreatic cancer cells by suppressing signal interactions in the tumor microenvironment and disrupting two positive feedback loops involving lactic acid production
2026 · Xiongfei Zhang, Xinyi Xia, et al. · Cellular & Molecular Biology Letters
San Wei Tan Xiang (SWTX) ameliorates depressive-like behaviors by modulating 6-phosphogluconate dehydrogenase (6PGD) activity in mice
2026 · Yuyan Ling, Ling Gu, et al. · Journal of Ethnopharmacology
Mechanism investigation of Caspase-8/GSDMC dependent immunogenic cell death induced by Ophiopogonin B in NSCLC cells
2022 · Zhihui Li, Ling Gu, et al. · Pharmacological Research - Modern Chinese Medicine
PDF
Works count: 7
Citation count: 18
H-index: 3
I10-index:
Year
Topic
Type